Unschuld PG, Ising M, Erhardt A; m.fl. (2008). «Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder». J Affect Disord. 105 (1-3): 177–84. PMID17573119. doi:10.1016/j.jad.2007.05.006.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Isensee B, Wittchen HU, Stein MB, Höfler M, Lieb R (2003). «Smoking increases the risk of panic: findings from a prospective community study». Arch. Gen. Psychiatry. 60 (7): 692–700. PMID12860773. doi:10.1001/archpsyc.60.7.692.CS1-vedlikehold: Flere navn: forfatterliste (link)
Breslau N, Klein DF (1999). «Smoking and panic attacks: an epidemiologic investigation». Arch. Gen. Psychiatry. 56 (12): 1141–7. PMID10591292. doi:10.1001/archpsyc.56.12.1141.
Pine DS, Klein RG, Coplan JD; m.fl. (2000). «Differential carbon dioxide sensitivity in childhood anxiety disorders and nonill comparison group». Arch. Gen. Psychiatry. 57 (10): 960–7. PMID11015814. doi:10.1001/archpsyc.57.10.960.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Gorman JM, Kent J, Martinez J, Browne S, Coplan J, Papp LA (2001). «Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism». Arch. Gen. Psychiatry. 58 (2): 125–31. PMID11177114. doi:10.1001/archpsyc.58.2.125.CS1-vedlikehold: Flere navn: forfatterliste (link)
Barlow DH, Gorman JM, Shear MK, Woods SW (2000). «Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial». JAMA. 283 (19): 2529–36. PMID10815116. doi:10.1001/jama.283.19.2529.CS1-vedlikehold: Flere navn: forfatterliste (link)
Marks IM, Swinson RP, Başoğlu M; m.fl. (1993). «Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto». Br J Psychiatry. 162: 776–87. PMID8101126. doi:10.1192/bjp.162.6.776.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999). «Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997». Eur Neuropsychopharmacol. 9 Suppl 6: S393–8. PMID10622685. doi:10.1016/S0924-977X(99)00050-4.CS1-vedlikehold: Flere navn: forfatterliste (link)
Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999). «International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders». J Clin Psychopharmacol. 19 (6 Suppl 2): 23S–29S. PMID10587281. doi:10.1097/00004714-199912002-00005.CS1-vedlikehold: Flere navn: forfatterliste (link)
Bandelow, B.; Zohar, J.; Hollander, E.; Kasper, S.; Möller, HJ.; World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (2002). «World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.». World J Biol Psychiatry. 3 (4): 171–99. PMID12516310. doi:10.3109/15622970209150621.
Diler RS, Birmaher B, Brent DA; m.fl. (2004). «Phenomenology of panic disorder in youth». Depress Anxiety. 20 (1): 39–43. PMID15368595. doi:10.1002/da.20018.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Biederman J, Faraone SV, Marrs A; m.fl. (1997). «Panic disorder and agoraphobia in consecutively referred children and adolescents». J Am Acad Child Adolesc Psychiatry. 36 (2): 214–23. PMID9031574. doi:10.1097/00004583-199702000-00012.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Berrocal C, Moreno FR, Cano J (2007). «Anxiety sensitivity and panic symptomology: the mediator role of hypochondriacal concerns». Span J Psychol. 10 (1): 159–66. PMID17549889.CS1-vedlikehold: Flere navn: forfatterliste (link)
Unschuld PG, Ising M, Erhardt A; m.fl. (2008). «Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder». J Affect Disord. 105 (1-3): 177–84. PMID17573119. doi:10.1016/j.jad.2007.05.006.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Isensee B, Wittchen HU, Stein MB, Höfler M, Lieb R (2003). «Smoking increases the risk of panic: findings from a prospective community study». Arch. Gen. Psychiatry. 60 (7): 692–700. PMID12860773. doi:10.1001/archpsyc.60.7.692.CS1-vedlikehold: Flere navn: forfatterliste (link)
Breslau N, Klein DF (1999). «Smoking and panic attacks: an epidemiologic investigation». Arch. Gen. Psychiatry. 56 (12): 1141–7. PMID10591292. doi:10.1001/archpsyc.56.12.1141.
Pine DS, Klein RG, Coplan JD; m.fl. (2000). «Differential carbon dioxide sensitivity in childhood anxiety disorders and nonill comparison group». Arch. Gen. Psychiatry. 57 (10): 960–7. PMID11015814. doi:10.1001/archpsyc.57.10.960.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Gorman JM, Kent J, Martinez J, Browne S, Coplan J, Papp LA (2001). «Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism». Arch. Gen. Psychiatry. 58 (2): 125–31. PMID11177114. doi:10.1001/archpsyc.58.2.125.CS1-vedlikehold: Flere navn: forfatterliste (link)
«Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association». Am J Psychiatry. 155 (5 Suppl): 1–34. 1998. PMID9585731.
Foldes-Busque, G.; Marchand, A.; Landry, P. (2007). «[Early detection and treatment of panic disorder with or without agoraphobia: update]». Can Fam Physician. 53 (10): 1686–93. PMID17934032.
Seguí, J.; Márquez, M.; Canet, J.; García, L. (1999). «[Causes of failure in psychopharmacological treatment of anxiety disorder]». Actas Esp Psiquiatr. 27 (4): 250–8. PMID10469946.
Barlow DH, Gorman JM, Shear MK, Woods SW (2000). «Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial». JAMA. 283 (19): 2529–36. PMID10815116. doi:10.1001/jama.283.19.2529.CS1-vedlikehold: Flere navn: forfatterliste (link)
Marks IM, Swinson RP, Başoğlu M; m.fl. (1993). «Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto». Br J Psychiatry. 162: 776–87. PMID8101126. doi:10.1192/bjp.162.6.776.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Wiborg IM, Dahl AA (1996). «Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?». Arch. Gen. Psychiatry. 53 (8): 689–94. PMID8694682.
[104] ^ Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999). "International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997". Depress Anxiety 9 (3): 107–16. PMID 10356648.
Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999). «Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997». Eur Neuropsychopharmacol. 9 Suppl 6: S393–8. PMID10622685. doi:10.1016/S0924-977X(99)00050-4.CS1-vedlikehold: Flere navn: forfatterliste (link)
Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999). «International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders». J Clin Psychopharmacol. 19 (6 Suppl 2): 23S–29S. PMID10587281. doi:10.1097/00004714-199912002-00005.CS1-vedlikehold: Flere navn: forfatterliste (link)
Damsa C, Lazignac C, Iancu R; m.fl. (2008). «[Panic disorders: differential diagnosis and care in emergencies]». Rev Med Suisse. 4 (144): 404–6, 408–9. PMID18320769.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Bandelow, B.; Zohar, J.; Hollander, E.; Kasper, S.; Möller, HJ.; World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (2002). «World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.». World J Biol Psychiatry. 3 (4): 171–99. PMID12516310. doi:10.3109/15622970209150621.
Stevens JC, Pollack MH (2005). «Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents». J Clin Psychiatry. 66 Suppl 2: 21–7. PMID15762816.
Diler RS, Birmaher B, Brent DA; m.fl. (2004). «Phenomenology of panic disorder in youth». Depress Anxiety. 20 (1): 39–43. PMID15368595. doi:10.1002/da.20018.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Biederman J, Faraone SV, Marrs A; m.fl. (1997). «Panic disorder and agoraphobia in consecutively referred children and adolescents». J Am Acad Child Adolesc Psychiatry. 36 (2): 214–23. PMID9031574. doi:10.1097/00004583-199702000-00012.CS1-vedlikehold: Eksplisitt bruk av m.fl. (link)CS1-vedlikehold: Flere navn: forfatterliste (link)
Essau CA, Conradt J, Petermann F (1999). «Frequency of panic attacks and panic disorder in adolescents». Depress Anxiety. 9 (1): 19–26. PMID9989346. doi:10.1002/(SICI)1520-6394(1999)9:1<19::AID-DA3>3.0.CO;2-# (inaktiv 2010-03-17).CS1-vedlikehold: Flere navn: forfatterliste (link)